3M Company Dossier

For the third quarter of fiscal year 2025, 3M Company generated GAAP sales of $6.5 billion and adjusted earnings per share of $2.19, supported by operational execution across its specialized industrial and electronics markets. The company continues to advance its strategic restructuring and productivity initiatives following the spin-off of its health care business.

Financial Highlights

* Reported GAAP sales of $6.5 billion and adjusted sales of $6.3 billion for the third quarter of 2025

* Achieved adjusted earnings per share of $2.19 and GAAP earnings per share of $1.55

* Recorded adjusted organic sales growth of 3.2 percent across the enterprise

* Generated operating cash flow of $1.8 billion and adjusted free cash flow of $1.3 billion

* Realized an adjusted free cash flow conversion rate of 111 percent

* Returned $0.9 billion to shareholders through dividends and share repurchases during the quarter

* Projected full-year 2025 adjusted earnings per share in the range of... Sign in / Sign up to learn more about 3M Company

Continue your research by chatting with our AI financial analyst about 3M Company. Ask follow-up questions, request specific analysis, or explore investment scenarios. All insights are grounded in verified financial data and SEC filings.

Start your analysis with these investor-focused questions:

• Given 3M Company's raised FY2025 guidance and strong Q3 performance, what are the primary drivers behind the adjusted operating margin expansion, and how sustainable are these gains as the company executes its operational excellence strategy?
• With ongoing legal liabilities from PFAS, how might these financial obligations impact 3M Company's capital allocation strategy, particularly its ability to fund R&D and future growth initiatives versus managing debt and shareholder returns?
• Analyzing 3M Company's Q3 FY2025 segment results, what factors are driving the outperformance in the Safety & Industrial and Transportation & Electronics segments compared to the slower growth in the Consumer business?
• Considering the successful spin-off of Solventum, evaluate 3M Company's new, more focused business model. What are its primary competitive advantages and risks within its core industrial and consumer markets?
• Based on the 'Buy' investment thesis, how does 3M Company's current valuation, with a forward P/E of 19.19, reflect the potential rewards of its turnaround strategy against the significant risks posed by litigation and macroeconomic cyclicality?